Sarcoma Clinical Trials
As one of the nation’s leading academic medical centers, UT Southwestern Medical Center takes part in a variety of clinical trials aimed at improving the outcomes of patients with different types of sarcoma.
UT Southwestern patients have opportunities to participate in clinical trials that test the most promising new sarcoma therapies before they’re available to the public.
Sarcoma trials at UT Southwestern include:
- A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma (ANNOUNCE 2)
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
- HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery